StreetAlpha
13F holdings · Q3 2026

Rice Hall James & Associates

San Diego, CA · files as Rice Hall James & Associates, LLC
Know the moment Rice Hall James & Associates filesYou follow Rice Hall James & Associates An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1230765

Rice Hall James & Associates reported 237 stocks worth $1.9B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are LGND (3.7%), ACIW (2.5%) and ARLO (2.4%). Compared with Q2 2026, the fund opened new positions in BFAM and STUB, added to FOUR, PBH and WIX, trimmed LGND, ACIW and ARLO and sold out of VREX, LNTH and CEVA.

Latest filing: what Rice Hall James & Associates did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
10 new38 added174 trimmed13 sold outBought about $103M · sold about $143M
New 10
See all 10 →
Added 38
See all 38 →
Trimmed 174
See all 174 →
Sold out 13
  • VREX$15.1M
  • Chart Inds Inc$7.9M
  • Crinetics Pharmace$7.3M
  • LNTH$4.9M
  • CEVA$4.6M
See all 13 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$1.9B−8.2% vs last quarter
Stocks held23710 new · 13 sold out
Top 5 weight13.1%spread out
Turnover16%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
LGND
Ligand Pharmaceuticals Inc
$69.9M3.7%224K−46K (−17%)8 of 8
2
ACIW
Aci Worldwide Inc
$47.7M2.5%977K−30K (−3%)8 of 8
3
ARLO
Arlo Technologies Inc
$45.3M2.4%3.7M−78K (−2%)8 of 8
4
ZD
Ziff Davis Inc
$45.1M2.4%795K−27K (−3%)8 of 8
5
XPO
Xpo Inc
$38.6M2.0%219K−5,463 (−2%)8 of 8
6
FN
Fabrinet
$36.3M1.9%86K−1,978 (−2%)8 of 8
7
FOUR
SHIFT4 Pmts Inc
$35.2M1.9%973K+99K (+11%)8 of 8
8
DFIN
Donnelley Finl Solutions Inc
$34.9M1.9%739K−36K (−5%)8 of 8
9
PBH
Prestige Consmr Healthcare I
$34.8M1.9%759K+70K (+10%)8 of 8
10
KNSA
Kiniksa Pharmaceuticals Intl
$34.8M1.8%466K−159K (−25%)8 of 8
🔒 227 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
VREX
Varex Imaging Corp
$15.1M1.4M
CHART INDS INC
$7.9M38K
CRINETICS PHARMACEUTICALS IN
$7.3M196K
LNTH
Lantheus Hldgs Inc
$4.9M44K
CEVA
Ceva Inc
$4.6M98K

🔒 Free account: see all 13.

Reported value

last 8 quarters
$1.8BQ4 '24
$1.7BQ1 '25
$1.9BQ2 '25
$1.8BQ3 '25
$1.8BQ4 '25
$1.8BQ1 '26
$2.1BQ2 '26
$1.9BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Rice Hall James & Associates 13F FAQ

What does Rice Hall James & Associates own?

Rice Hall James & Associates reported 237 stocks worth $1.9B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are LGND (3.7%), ACIW (2.5%) and ARLO (2.4%). The table above lists every position in the filing (the top 10 without an account).

What did Rice Hall James & Associates buy and sell in Q3 2026?

Compared with Q2 2026: 10 new positions, 38 added to, 174 trimmed and 13 sold out. New positions include BFAM and STUB. It sold all of VREX, LNTH and CEVA.

When will Rice Hall James & Associates file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Rice Hall James & Associates's portfolio worth?

The Q3 2026 filing reports $1.9B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.